Search research articles
Contact Us
Filters
Showing results (311-320 of 361) with videos related to
Page
of 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Shuang G Zhao, William S Chen, Rajdeep Das, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2018
Phase I Study of CTT1057, an <sup>18</sup>F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
Spencer C Behr, Rahul Aggarwal, Henry F VanBrocklin, et al.
The Journal of Clinical Investigation
|
October 1, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
Xiaolin Zhu, Tatyanah Farsh, Daniël Vis, et al.
Urologic Oncology
|
July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer
Daniel H Kwon, Li Zhang, David A Quigley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Michael J Morris, Glenn Heller, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Jonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Clinical Genitourinary Cancer
|
June 14, 2023
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin
Tanya Jindal, Li Zhang, Prianka Deshmukh, et al.
Genome Biology
|
April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Thaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Bladder cancer
James E Montie, Peter E Clark, Mario A Eisenberger, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 361) with videos related to
Sort By:
Page
of 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Shuang G Zhao, William S Chen, Rajdeep Das, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2018
Phase I Study of CTT1057, an <sup>18</sup>F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
Spencer C Behr, Rahul Aggarwal, Henry F VanBrocklin, et al.
The Journal of Clinical Investigation
|
October 1, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
Xiaolin Zhu, Tatyanah Farsh, Daniël Vis, et al.
Urologic Oncology
|
July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer
Daniel H Kwon, Li Zhang, David A Quigley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Michael J Morris, Glenn Heller, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Jonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Clinical Genitourinary Cancer
|
June 14, 2023
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin
Tanya Jindal, Li Zhang, Prianka Deshmukh, et al.
Genome Biology
|
April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Thaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Bladder cancer
James E Montie, Peter E Clark, Mario A Eisenberger, et al.
Page
of 37